Circulating tumor cells reveal early predictors of disease progression in patients with stage III NSCLC undergoing chemoradiation and immunotherapy
Open Access
- 22 January 2024
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 43 (2) , 113687
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (5-R33-CA-202867-02)
- National Institutes of Health (U01CA210152)
- National Institutes of Health (1-R01-CA-208335-01-A1)
This publication has 65 references indexed in Scilit:
- Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheetsNature Nanotechnology, 2013
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunityCurrent Opinion in Immunology, 2012
- Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent ApproachesJournal of Thoracic Oncology, 2012
- The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN)Annals of Oncology, 2011
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- A framework for oligonucleotide microarray preprocessingBioinformatics, 2010
- ExoCarta: A compendium of exosomal proteins and RNAProteomics, 2009
- Highly tumorigenic lung cancer CD133 + cells display stem-like features and are spared by cisplatin treatmentProceedings of the National Academy of Sciences, 2009
- Exosomal MicroRNA: A Diagnostic Marker for Lung CancerClinical Lung Cancer, 2009
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004